<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>abacavir</title><link>http://www.unboundmedicine.com/medline/ebm/research/abacavir</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Treatment of HIV infection: Swedish recommendations 2009.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922061/full_citation/Treatment_of_HIV_infection:_Swedish_recommendations_2009_</link><description>Josephson F, Albert J, Flamholc L, et al. <br/><span class="title">Treatment of HIV infection: Swedish recommendations 2009. [JOURNAL ARTICLE]</span><br/><span class="source" title="Scandinavian journal of infectious diseases">Scand J Infect Dis 2009; 41(11-12):788-807.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922061/abstract/Treatment_of_HIV_infection:_Swedish_recommendations_2009_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922061/full_citation/Treatment_of_HIV_infection:_Swedish_recommendations_2009_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922061/Treatment_of_HIV_infection:_Swedish_recommendations_2009_">Find Related Articles</a> </description></item><item><title>Gateways to clinical trials.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19907722/full_citation/Gateways_to_clinical_trials_</link><description>Tomillero A, Moral MA <br/><span class="title">Gateways to clinical trials. [Journal Article]</span><br/><span class="source" title="Methods and findings in experimental and clinical pharmacology">Methods Find Exp Clin Pharmacol 2009 Sep; 31(7):463-93.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19907722/abstract/Gateways_to_clinical_trials_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19907722/full_citation/Gateways_to_clinical_trials_">Full Citation</a></description></item><item><title>Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19907359/full_citation/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_</link><description>Vaz P, Chaix ML, Jani I, et al. <br/><span class="title">Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Pediatric infectious disease journal">Pediatr Infect Dis J 2009 Nov 10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19907359/abstract/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19907359/full_citation/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_">Full Citation</a></description></item><item><title>[Treatment of chronic hepatitis C in HIV-infected patients]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19375043/full_citation/[Treatment_of_chronic_hepatitis_C_in_HIV_infected_patients]</link><description>Bani-Sadr F <br/><span class="title">[Treatment of chronic hepatitis C in HIV-infected patients] [English Abstract, Journal Article]</span><br/><span class="source" title="Gastroentérologie clinique et biologique">Gastroenterol Clin Biol 2009 Mar.:S97-S103.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19375043/abstract/[Treatment_of_chronic_hepatitis_C_in_HIV_infected_patients]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19375043/full_citation/[Treatment_of_chronic_hepatitis_C_in_HIV_infected_patients]">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19375043/[Treatment_of_chronic_hepatitis_C_in_HIV_infected_patients]">Find Related Articles</a> </description></item><item><title>Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19891054/full_citation/Changes_in_biomarkers_of_cardiovascular_risk_after_a_switch_to_abacavir_in_HIV_1_infected_individuals_receiving_combination_antiretroviral_therapy_</link><description>Kristoffersen US, Kofoed K, Kronborg G, et al. <br/><span class="title">Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="HIV medicine">HIV Med 2009 Nov; 10(10):627-33.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19891054/abstract/Changes_in_biomarkers_of_cardiovascular_risk_after_a_switch_to_abacavir_in_HIV_1_infected_individuals_receiving_combination_antiretroviral_therapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19891054/full_citation/Changes_in_biomarkers_of_cardiovascular_risk_after_a_switch_to_abacavir_in_HIV_1_infected_individuals_receiving_combination_antiretroviral_therapy_">Full Citation</a></description></item><item><title>PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19878352/full_citation/PENTA_2009_guidelines_for_the_use_of_antiretroviral_therapy_in_paediatric_HIV_1_infection_</link><description> <br/><span class="title">PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. [Journal Article]</span><br/><span class="source" title="HIV medicine">HIV Med 2009 Nov; 10(10):591-613.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19878352/abstract/PENTA_2009_guidelines_for_the_use_of_antiretroviral_therapy_in_paediatric_HIV_1_infection_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19878352/full_citation/PENTA_2009_guidelines_for_the_use_of_antiretroviral_therapy_in_paediatric_HIV_1_infection_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19878352/PENTA_2009_guidelines_for_the_use_of_antiretroviral_therapy_in_paediatric_HIV_1_infection_">Find Related Articles</a> </description></item><item><title>Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19863618/full_citation/Implementing_the_number_needed_to_harm_in_clinical_practice:_risk_of_myocardial_infarction_in_HIV_1_infected_patients_treated_with_abacavir_</link><description>Kowalska J, Kirk O, Mocroft A, et al. <br/><span class="title">Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir. [JOURNAL ARTICLE]</span><br/><span class="source" title="HIV medicine">HIV Med 2009 Oct 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19863618/abstract/Implementing_the_number_needed_to_harm_in_clinical_practice:_risk_of_myocardial_infarction_in_HIV_1_infected_patients_treated_with_abacavir_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19863618/full_citation/Implementing_the_number_needed_to_harm_in_clinical_practice:_risk_of_myocardial_infarction_in_HIV_1_infected_patients_treated_with_abacavir_">Full Citation</a></description></item><item><title>Successful implementation of a national HLA-B*5701 genetic testing service in Canada.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19843279/full_citation/Successful_implementation_of_a_national_HLA_B_5701_genetic_testing_service_in_Canada_</link><description>Lalonde RG, Thomas R, Rachlis A, et al. <br/><span class="title">Successful implementation of a national HLA-B*5701 genetic testing service in Canada. [JOURNAL ARTICLE]</span><br/><span class="source" title="Tissue antigens">Tissue Antigens 2009 Oct 15.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19843279/abstract/Successful_implementation_of_a_national_HLA_B_5701_genetic_testing_service_in_Canada_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19843279/full_citation/Successful_implementation_of_a_national_HLA_B_5701_genetic_testing_service_in_Canada_">Full Citation</a></description></item><item><title>Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19842973/full_citation/Simplification_of_Antiretroviral_Therapy_with_Tenofovir_Emtricitabine_or_Abacavir_Lamivudine:_A_Randomized_96_Week_Trial_</link><description>Martin A, Bloch M, Amin J, et al. <br/><span class="title">Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical infectious diseases : an official publication of the Infectious Diseases Society of America">Clin Infect Dis 2009 Oct 20.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19842973/abstract/Simplification_of_Antiretroviral_Therapy_with_Tenofovir_Emtricitabine_or_Abacavir_Lamivudine:_A_Randomized_96_Week_Trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19842973/full_citation/Simplification_of_Antiretroviral_Therapy_with_Tenofovir_Emtricitabine_or_Abacavir_Lamivudine:_A_Randomized_96_Week_Trial_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19842973/Simplification_of_Antiretroviral_Therapy_with_Tenofovir_Emtricitabine_or_Abacavir_Lamivudine:_A_Randomized_96_Week_Trial_">Find Related Articles</a> </description></item><item><title>A Study of HIV Provider Attitudes Toward HLA-B*5701 Testing in the United States.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19839743/full_citation/A_Study_of_HIV_Provider_Attitudes_Toward_HLA_B_5701_Testing_in_the_United_States_</link><description>Watson ME, Patel LG, Ha B, et al. <br/><span class="title">A Study of HIV Provider Attitudes Toward HLA-B*5701 Testing in the United States. [JOURNAL ARTICLE]</span><br/><span class="source" title="AIDS patient care and STDs">AIDS Patient Care STDS 2009 Oct 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19839743/abstract/A_Study_of_HIV_Provider_Attitudes_Toward_HLA_B_5701_Testing_in_the_United_States_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19839743/full_citation/A_Study_of_HIV_Provider_Attitudes_Toward_HLA_B_5701_Testing_in_the_United_States_">Full Citation</a></description></item></channel></rss>